Article Details

Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run

Retrieved on: 2024-04-16 12:41:10

Tags for this article:

Click the tags to see associated articles and topics

Nascent Prepares for Pivotal Phase II Research with Fresh Manufacturing Run. View article details on hiswai:

Excerpt

... monoclonal antibodies targeting various cancer types, announces . ... The Company's lead candidate, Pritumumab (PTB), is a human monoclonal Antibody ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up